Health-Related Quality of Life (HRQL) in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated With Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin 2020, 4 (6), s122. https://doi.org/10.25251/skin.4.supp.122.